Structure and mechanics of integrin-based cell adhesion

Current Opinion in Cell Biology

Volumn 19, Issue 5, 2007, Pages 495-507

  Arnaout, M Amin ^a   Goodman, Simon L ^b   Xiong, Jian Ping ^a  

^a Structural Biology Program   (United States)

^b Merck Serono GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BETA INTEGRIN; VITRONECTIN RECEPTOR;

CELL ADHESION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANIMALS; CELL ADHESION; CRYSTALLOGRAPHY, X-RAY; CYTOSKELETAL PROTEINS; FOCAL ADHESIONS; INTEGRINS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION; TALIN;

EID: 35648978998     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2007.08.002     Document Type: Review

References (110)

1. Hynes R.O. Integrins: a family of cell surface receptors. Cell 48 (1987) 549-554
2. Geiger B., Bershadsky A., Pankov R., and Yamada K.M. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2 (2001) 793-805
3. Zaidel-Bar R., Ballestrem C., Kam Z., and Geiger B. Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J Cell Sci 116 (2003) 4605-4613
4. Vogel V., and Sheetz M. Local force and geometry sensing regulate cell functions. Nat Rev Mol Cell Biol 7 (2006) 265-275
5. Michishita M., Videm V., and Arnaout M.A. A novel divalent cation-binding site in the A domain of the beta 2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell 72 (1993) 857-867
6. Lee J.O., Bankston L.A., Arnaout M.A., and Liddington R.C. Two conformations of the integrin A-domain (I-domain): a pathway for activation?. Structure 3 (1995) 1333-1340
7. Lee J.O., Rieu P., Arnaout M.A., and Liddington R. Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18). Cell 80 (1995) 631-638
8. Arnaout M.A., Mahalingam B., and Xiong J.P. Integrin structure, allostery, and bidirectional signaling. Annu Rev Cell Dev Biol 21 (2005) 381-410
9. Li R., Rieu P., Griffith D.L., Scott D., and Arnaout M.A. Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol 143 (1998) 1523-1534
10. Xiong J.P., Li R., Essafi M., Stehle T., and Arnaout M.A. An isoleucine-based allosteric switch controls affinity and shape shifting in integrin CD11b A-domain. J Biol Chem 275 (2000) 38762-38767
11. Huth J.R., Olejniczak E.T., Mendoza R., Liang H., Harris E.A., Lupher Jr. M.L., Wilson A.E., Fesik S.W., and Staunton D.E. NMR and mutagenesis evidence for an I domain allosteric site that regulates lymphocyte function-associated antigen 1 ligand binding. Proc Natl Acad Sci USA 97 (2000) 5231-5236
12. Shimaoka M., Xiao T., Liu J.H., Yang Y., Dong Y., Jun C.D., McCormack A., Zhang R., Joachimiak A., Takagi J., et al. Structures of the alphaL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation. Cell 112 (2003) 99-111
13. Xiong J.P., Stehle T., Diefenbach B., Zhang R., Dunker R., Scott D.L., Joachimiak A., Goodman S.L., and Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science 294 (2001) 339-345
14. Xiong J.P., Stehle T., Zhang R., Joachimiak A., Frech M., Goodman S.L., and Arnaout M.A. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science 296 (2002) 151-155
15. Xiong J.P., Stehle T., Goodman S.L., and Arnaout M.A. A novel adaptation of the integrin PSI domain revealed from its crystal structure. J Biol Chem 279 (2004) 40252-40254
16. Isaji T., Sato Y., Zhao Y., Miyoshi E., Wada Y., Taniguchi N., and Gu J. N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function. J Biol Chem 281 (2006) 33258-33267. Specific glycosylation sites on α5β1 that regulate dimerization and transport.
17. Sen M., and Legge G.B. Pactolus i-domain: functional switching of the Rossmann fold. Proteins 68 (2007) 626-635
18. Cheng M., Foo S.Y., Shi M.L., Tang R.H., Kong L.S., Law S.K., and Tan S.M. Mutation of a conserved asparagine in the I-like domain promotes constitutively active integrins {alpha}Lbeta2 and {alpha}IIbbeta3. J Biol Chem 282 (2007) 18225-18232
19. Xiao T., Takagi J., Coller B.S., Wang J.H., and Springer T.A. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432 (2004) 59-67
20. Luo B.H., Takagi J., and Springer T.A. Locking the beta3 integrin I-like domain into high and low affinity conformations with disulfides. J Biol Chem 279 (2004) 10215-10221
21. Yang W., Shimaoka M., Chen J., and Springer T.A. Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions. Proc Natl Acad Sci USA 101 (2004) 2333-2338
22. Lu C., Shimaoka M., Zang Q., Takagi J., and Springer T.A. Locking in alternate conformations of the integrin alphaLbeta2 I domain with disulfide bonds reveals functional relationships among integrin domains. Proc Natl Acad Sci USA 98 (2001) 2393-2398
23. Nishida N., Xie C., Shimaoka M., Cheng Y., Walz T., and Springer T.A. Activation of leukocyte beta(2) integrins by conversion from bent to extended conformations. Immunity 25 (2006) 583-594
24. Xiong J.P., Stehle T., Goodman S.L., and Arnaout M.A. New insights into the structural basis of integrin activation. Blood 102 (2003) 1155-1159
25. Gupta V., Gylling A., Alonso J.L., Sugimori T., Ianakiev P., Xiong J.P., and Arnaout M.A. The {beta}-tail domain ({beta}TD) regulates physiologic ligand binding to integrin CD11b/CD18. Blood (2006)
26. Zhu J., Boylan B., Luo B.H., Newman P.J., and Springer T.A. Tests of the extension and deadbolt models of integrin activation. J Biol Chem 282 (2007) 11914-11920
27. Alonso J.L., Essafi M., Xiong J.P., Stehle T., and Arnaout M.A. Does the integrin alphaA domain act as a ligand for its betaA domain?. Curr Biol 12 (2002) R340-R342
28. Takagi J., Petre B.M., Walz T., and Springer T.A. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110 (2002) 599-611
29. Takagi J., Strokovich K., Springer T.A., and Walz T. Structure of integrin alpha5beta1 in complex with fibronectin. EMBO J 22 (2003) 4607-4615
30. Adair B.D., Xiong J.P., Maddock C., Goodman S.L., Arnaout M.A., and Yeager M. Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin. J Cell Biol 168 (2005) 1109-1118. Recombinant extracellular domains of αvβ3 as crystallized in reference [13] remain bent when bound to a macromolecular fibronectin fragment. But an increase in angle of 11 ± 4° between the Hybrid and βA domain is seen.
31. Adair B.D., and Yeager M. Three-dimensional model of the human platelet integrin alpha IIbbeta 3 based on electron cryomicroscopy and X-ray crystallography. Proc Natl Acad Sci USA 99 (2002) 14059-14064. TEM study revealing that the transmembrane helices of αIIb and β3 pack closely in situ and that the receptor does not depart the membrane orthogonally. Evidence for a partially bent structure in a context more native than reference [13].
32. Iwasaki K., Mitsuoka K., Fujiyoshi Y., Fujisawa Y., Kikuchi M., Sekiguchi K., and Yamada T. Electron tomography reveals diverse conformations of integrin alphaIIbbeta3 in the active state. J Struct Biol 150 (2005) 259-267
33. •], while questioning the use of bilaterally amputated integrins in structural studies.
34. Luo B.H., and Springer T.A. Integrin structures and conformational signaling. Curr Opin Cell Biol 18 (2006) 579-586
35. Craig R., and Woodhead J.L. Structure and function of myosin filaments. Curr Opin Struct Biol 16 (2006) 204-212
36. Chigaev A., Buranda T., Dwyer D.C., Prossnitz E.R., and Sklar L.A. FRET detection of cellular alpha4-integrin conformational activation. Biophys J 85 (2003) 3951-3962
37. Chigaev A., Waller A., Zwartz G.J., Buranda T., and Sklar L.A. Regulation of cell adhesion by affinity and conformational unbending of alpha4beta1 integrin. J Immunol 178 (2007) 6828-6839. This and the next paper use FRET between a lipophilic membrane acceptor and an α4β1 mimetic to show a change in distance between integrin head and membrane: inactive-to-active 2.5 nm-7.5 nm, that is shorter than the combined length of the Calf domains. Although this is apparently incompatible with a change from a 'folded' to fully 'extended' structures, it is a signal-averaging technique and so equivocal. Interestingly, the FRET signal, and hence the mean distance of binding site from membrane does not change when the receptor affinity is increased using PMA.
38. Calzada M.J., Alvarez M.V., and Gonzalez-Rodriguez J. Agonist-specific structural rearrangements of integrin alpha IIbbeta 3. Confirmation of the bent conformation in platelets at rest and after activation. J Biol Chem 277 (2002) 39899-39908
39. Hussain M.A., Agnihotri A., and Siedlecki C.A. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers. Langmuir 21 (2005) 6979-6986. An initial effort to using new technologies.
40. Ingber D.E. Mechanosensation through integrins: cells act locally but think globally. Proc Natl Acad Sci USA 100 (2003) 1472-1474
41. Garcia-Alvarez B., de Pereda J.M., Calderwood D.A., Ulmer T.S., Critchley D., Campbell I.D., Ginsberg M.H., and Liddington R.C. Structural determinants of integrin recognition by talin. Mol Cell 11 (2003) 49-58
42. Wegener K.L., Partridge A.W., Han J., Pickford A.R., Liddington R.C., Ginsberg M.H., and Campbell I.D. Structural basis of integrin activation by talin. Cell 128 (2007) 171-182. Elegant description of the interaction of talin with the β3 cytoplasmic domain.
43. McCleverty C.J., Lin D.C., and Liddington R.C. Structure of the PTB domain of tensin1 and a model for its recruitment to fibrillar adhesions. Protein Sci 16 (2007) 1223-1229
44. Bakolitsa C., Cohen D.M., Bankston L.A., Bobkov A.A., Cadwell G.W., Jennings L., Critchley D.R., Craig S.W., and Liddington R.C. Structural basis for vinculin activation at sites of cell adhesion. Nature 430 (2004) 583-586
45. Borgon R.A., Vonrhein C., Bricogne G., Bois P.R., and Izard T. Crystal structure of human vinculin. Structure 12 (2004) 1189-1197
46. Gingras A.R., Vogel K.P., Steinhoff H.J., Ziegler W.H., Patel B., Emsley J., Critchley D.R., Roberts G.C., and Barsukov I.L. Structural and dynamic characterization of a vinculin binding site in the talin rod. Biochemistry 45 (2006) 1805-1817
47. Bois P.R., Borgon R.A., Vonrhein C., and Izard T. Structural dynamics of alpha-actinin-vinculin interactions. Mol Cell Biol 25 (2005) 6112-6122
48. Kelly D.F., Taylor D.W., Bakolitsa C., Bobkov A.A., Bankston L., Liddington R.C., and Taylor K.A. Structure of the alpha-actinin-vinculin head domain complex determined by cryo-electron microscopy. J Mol Biol 357 (2006) 562-573
49. Kiema T., Lad Y., Jiang P., Oxley C.L., Baldassarre M., Wegener K.L., Campbell I.D., Ylanne J., and Calderwood D.A. The molecular basis of filamin binding to integrins and competition with talin. Mol Cell 21 (2006) 337-347. A second elegant study showing that filamin interaction with β7 cytoplasmic domain has different structural consequences from talin interaction. The binding sites partially overlap, and the authors show biochemically that they compete. This reveals a new mechanism of integrin-cytoskeletal regulation.
50. Izard T., Evans G., Borgon R.A., Rush C.L., Bricogne G., and Bois P.R. Vinculin activation by talin through helical bundle conversion. Nature 427 (2004) 171-175
51. Tadokoro S., Shattil S.J., Eto K., Tai V., Liddington R.C., de Pereda J.M., Ginsberg M.H., and Calderwood D.A. Talin binding to integrin beta tails: a final common step in integrin activation. Science 302 (2003) 103-106
52. Jiang G., Giannone G., Critchley D.R., Fukumoto E., and Sheetz M.P. Two-piconewton slip bond between fibronectin and the cytoskeleton depends on talin. Nature 424 (2003) 334-337
53. Giannone G., Jiang G., Sutton D.H., Critchley D.R., and Sheetz M.P. Talin1 is critical for force-dependent reinforcement of initial integrin-cytoskeleton bonds but not tyrosine kinase activation. J Cell Biol 163 (2003) 409-419
54. Lafuente E.M., van Puijenbroek A.A., Krause M., Carman C.V., Freeman G.J., Berezovskaya A., Constantine E., Springer T.A., Gertler F.B., and Boussiotis V.A. RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion. Dev Cell 7 (2004) 585-595
55. Han J., Lim C.J., Watanabe N., Soriani A., Ratnikov B., Calderwood D.A., Puzon-McLaughlin W., Lafuente E.M., Boussiotis V.A., Shattil S.J., et al. Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol 16 (2006) 1796-1806
56. Martel V., Racaud-Sultan C., Dupe S., Marie C., Paulhe F., Galmiche A., Block M.R., and Albiges-Rizo C. Conformation, localization, and integrin binding of talin depend on its interaction with phosphoinositides. J Biol Chem 276 (2001) 21217-21227
57. Yan B., Calderwood D.A., Yaspan B., and Ginsberg M.H. Calpain cleavage promotes talin binding to the beta 3 integrin cytoplasmic domain. J Biol Chem 276 (2001) 28164-28170
58. Vinogradova O., Velyvis A., Velyviene A., Hu B., Haas T., Plow E., and Qin J. A structural mechanism of integrin alpha(IIb)beta(3)" inside-out" activation as regulated by its cytoplasmic face. Cell 110 (2002) 587-597
59. Hughes P.E., Diaz-Gonzalez F., Leong L., Wu C., McDonald J.A., Shattil S.J., and Ginsberg M.H. Breaking the integrin hinge. J Biol Chem 271 (1996) 6571-6574
60. Kim M., Carman C.V., and Springer T.A. Bidirectional transmembrane signaling by cytoplasmic domain separation in integrins. Science 301 (2003) 1720-1725
61. Calderwood D.A., Huttenlocher A., Kiosses W.B., Rose D.M., Woodside D.G., Schwartz M.A., and Ginsberg M.H. Increased filamin binding to beta-integrin cytoplasmic domains inhibits cell migration. Nat Cell Biol 3 (2001) 1060-1068
62. Tanentzapf G., and Brown N.H. An interaction between integrin and the talin FERM domain mediates integrin activation but not linkage to the cytoskeleton. Nat Cell Biol 8 (2006) 601-606
63. Moes M., Rodius S., Coleman S.J., Monkley S.J., Goormaghtigh E., Tremuth L., Kox C., van der Holst P.P., Critchley D.R., and Kieffer N. The integrin binding site 2 (IBS2) in the talin rod domain is essential for linking integrin beta subunits to the cytoskeleton. J Biol Chem 282 (2007) 17280-17288. The sites in the talin tail revealed, which after binding of the talin head domain regulate propagation of the ECM-cytoskeleton signaling path.
64. Cluzel C., Saltel F., Lussi J., Paulhe F., Imhof B.A., and Wehrle-Haller B. The mechanisms and dynamics of (alpha)v(beta)3 integrin clustering in living cells. J Cell Biol 171 (2005) 383-392
65. Alon R., Feigelson S.W., Manevich E., Rose D.M., Schmitz J., Overby D.R., Winter E., Grabovsky V., Shinder V., Matthews B.D., et al. Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the alpha4-cytoplasmic domain. J Cell Biol 171 (2005) 1073-1084
66. Chen H., Choudhury D.M., and Craig S.W. Coincidence of actin filaments and talin is required to activate vinculin. J Biol Chem 281 (2006) 40389-40398
67. Bois P.R., O'Hara B.P., Nietlispach D., Kirkpatrick J., and Izard T. The vinculin binding sites of talin and alpha-actinin are sufficient to activate vinculin. J Biol Chem 281 (2006) 7228-7236
68. Fillingham I., Gingras A.R., Papagrigoriou E., Patel B., Emsley J., Critchley D.R., Roberts G.C., and Barsukov I.L. A vinculin binding domain from the talin rod unfolds to form a complex with the vinculin head. Structure 13 (2005) 65-74
69. Brown M.C., and Turner C.E. Paxillin: adapting to change. Physiol Rev 84 (2004) 1315-1339
70. Mitra S.K., Hanson D.A., and Schlaepfer D.D. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6 (2005) 56-68
71. Arold S.T., Hoellerer M.K., and Noble M.E. The structural basis of localization and signaling by the focal adhesion targeting domain. Structure 10 (2002) 319-327
72. Hayashi I., Vuori K., and Liddington R.C. The focal adhesion targeting (FAT) region of focal adhesion kinase is a four-helix bundle that binds paxillin. Nat Struct Biol 9 (2002) 101-106
73. Lietha D., Cai X., Ceccarelli D.F., Li Y., Schaller M.D., and Eck M.J. Structural basis for the autoinhibition of focal adhesion kinase. Cell 129 (2007) 1177-1187
74. Sawada Y., Tamada M., Dubin-Thaler B.J., Cherniavskaya O., Sakai R., Tanaka S., and Sheetz M.P. Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127 (2006) 1015-1026. A nice study that identifies p130Cas as a primary sensor and transducer of force at focal adhesions.
75. Laukaitis C.M., Webb D.J., Donais K., and Horwitz A.F. Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J Cell Biol 153 (2001) 1427-1440
76. Kelly D.F., and Taylor K.A. Identification of the beta1-integrin binding site on alpha-actinin by cryoelectron microscopy. J Struct Biol 149 (2005) 290-302
77. Li B., and Trueb B. Analysis of the alpha-actinin/zyxin interaction. J Biol Chem 276 (2001) 33328-33335
78. Fradelizi J., Noireaux V., Plastino J., Menichi B., Louvard D., Sykes C., Golsteyn R.M., and Friederich E. ActA and human zyxin harbour Arp2/3-independent actin-polymerization activity. Nat Cell Biol 3 (2001) 699-707
79. Knezevic I., Leisner T.M., and Lam S.C. Direct binding of the platelet integrin alphaIIbbeta3 (GPIIb-IIIa) to talin. Evidence that interaction is mediated through the cytoplasmic domains of both alphaIIb and beta3. J Biol Chem 271 (1996) 16416-16421
80. Yamniuk A.P., Ishida H., and Vogel H.J. The interaction between calcium- and integrin-binding protein 1 and the alphaIIb integrin cytoplasmic domain involves a novel C-terminal displacement mechanism. J Biol Chem 281 (2006) 26455-26464
81. Yuan W., Leisner T.M., McFadden A.W., Wang Z., Larson M.K., Clark S., Boudignon-Proudhon C., Lam S.C., and Parise L.V. CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activation. J Cell Biol 172 (2006) 169-175
82. Lim C.J., Han J., Yousefi N., Ma Y., Amieux P.S., McKnight G.S., Taylor S.S., and Ginsberg M.H. Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins. Nat Cell Biol 9 (2007) 415-421
83. Nishiya N., Kiosses W.B., Han J., and Ginsberg M.H. An alpha4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat Cell Biol 7 (2005) 343-352
84. Katagiri K., Maeda A., Shimonaka M., and Kinashi T. RAPL, a Rap1-binding molecule that mediates Rap1-induced adhesion through spatial regulation of LFA-1. Nat Immunol 4 (2003) 741-748
85. Mattila E., Pellinen T., Nevo J., Vuoriluoto K., Arjonen A., and Ivaska J. Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP. Nat Cell Biol 7 (2005) 78-85
86. ••]) reveal the power of new methodologies in examining motion of structural and regulatory focal-adhesion proteins with actomyosin motors at focal adhesions in live cells.
87. Hu K., Ji L., Applegate K.T., Danuser G., and Waterman-Storer C.M. Differential transmission of actin motion within focal adhesions. Science 315 (2007) 111-115
88. Evans E.A., and Calderwood D.A. Forces and bond dynamics in cell adhesion. Science 316 (2007) 1148-1153
89. Defilippi P., Di Stefano P., and Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16 (2006) 257-263
90. Arias-Salgado E.G., Lizano S., Sarkar S., Brugge J.S., Ginsberg M.H., and Shattil S.J. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci USA 100 (2003) 13298-13302
91. Arias-Salgado E.G., Lizano S., Shattil S.J., and Ginsberg M.H. Specification of the direction of adhesive signaling by the integrin beta cytoplasmic domain. J Biol Chem 280 (2005) 29699-29707
92. von Wichert G., Jiang G., Kostic A., De Vos K., Sap J., and Sheetz M.P. RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin-cytoskeleton linkages. J Cell Biol 161 (2003) 143-153
93. Woodside D.G., Obergfell A., Leng L., Wilsbacher J.L., Miranti C.K., Brugge J.S., Shattil S.J., and Ginsberg M.H. Activation of Syk protein tyrosine kinase through interaction with integrin beta cytoplasmic domains. Curr Biol 11 (2001) 1799-1804
94. Ling K., Doughman R.L., Iyer V.V., Firestone A.J., Bairstow S.F., Mosher D.F., Schaller M.D., and Anderson R.A. Tyrosine phosphorylation of type Igamma phosphatidylinositol phosphate kinase by Src regulates an integrin-talin switch. J Cell Biol 163 (2003) 1339-1349
95. de Pereda J.M., Wegener K.L., Santelli E., Bate N., Ginsberg M.H., Critchley D.R., Campbell I.D., and Liddington R.C. Structural basis for phosphatidylinositol phosphate kinase type Igamma binding to talin at focal adhesions. J Biol Chem 280 (2005) 8381-8386
96. Lee S.Y., Voronov S., Letinic K., Nairn A.C., Di Paolo G., and De Camilli P. Regulation of the interaction between PIPKI gamma and talin by proline-directed protein kinases. J Cell Biol 168 (2005) 789-799
97. Ling K., Doughman R.L., Firestone A.J., Bunce M.W., and Anderson R.A. Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. Nature 420 (2002) 89-93
98. von Wichert G., Haimovich B., Feng G.S., and Sheetz M.P. Force-dependent integrin-cytoskeleton linkage formation requires downregulation of focal complex dynamics by Shp2. EMBO J 22 (2003) 5023-5035
99. Legate K.R., Montanez E., Kudlacek O., and Fassler R. ILK, PINCH and parvin: the tIPP of integrin signalling. Nat Rev Mol Cell Biol 7 (2006) 20-31
100. Orr A.W., Ginsberg M.H., Shattil S.J., Deckmyn H., and Schwartz M.A. Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell 17 (2006) 4686-4697. Revealing study, which explains how ligation of one integrin can suppress the activation of others: different pathways are activated involving PKA when α2β1 activation suppresses αvβ3, and PKCα when α5β1 suppresses α2β1.
101. Ginsberg M.H., Partridge A., and Shattil S.J. Integrin regulation. Curr Opin Cell Biol 17 (2005) 509-516
102. Stefansson A., Armulik A., Nilsson I., von Heijne G., and Johansson S. Determination of N- and C-terminal borders of the transmembrane domain of integrin subunits. J Biol Chem 279 (2004) 21200-21205
103. Partridge A.W., Liu S., Kim S., Bowie J.U., and Ginsberg M.H. Transmembrane domain helix packing stabilizes integrin alpha IIbbeta 3 in the low affinity state. J Biol Chem (2004)
104. Vinogradova O., Vaynberg J., Kong X., Haas T.A., Plow E.F., and Qin J. Membrane-mediated structural transitions at the cytoplasmic face during integrin activation. Proc Natl Acad Sci USA 101 (2004) 4094-4099
105. Gottschalk K.E. A coiled-coil structure of the alphaIIbbeta3 integrin transmembrane and cytoplasmic domains in its resting state. Structure 13 (2005) 703-712
106. Gottschalk K.E., and Kessler H. A computational model of transmembrane integrin clustering. Structure 12 (2004) 1109-1116
107. Gottschalk K.E., and Kessler H. Evidence for hetero-association of transmembrane helices of integrins. FEBS Lett 557 (2004) 253-258
108. Luo B.H., Carman C.V., Takagi J., and Springer T.A. Disrupting integrin transmembrane domain heterodimerization increases ligand binding affinity, not valency or clustering. Proc Natl Acad Sci USA 102 (2005) 3679-3684
109. Yin H., Slusky J.S., Berger B.W., Walters R.S., Vilaire G., Litvinov R.I., Lear J.D., Caputo G.A., Bennett J.S., and DeGrado W.F. Computational design of peptides that target transmembrane helices. Science 315 (2007) 1817-1822. An intriguing new pharmacological approach to structural and functional analysis of protein transmembrane domains.
110. Li R., Mitra N., Gratkowski H., Vilaire G., Litvinov R., Nagasami C., Weisel J.W., Lear J.D., DeGrado W.F., and Bennett J.S. Activation of integrin alphaIIbbeta3 by modulation of transmembrane helix associations. Science 300 (2003) 795-798